article thumbnail

Fluctuating Cholesterol Tied to Higher Dementia Risk

Med Page Today

(MedPage Today) -- Year-to-year fluctuations in total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels were tied to higher risks of cognitive decline and dementia, a study of nearly 10,000 older adults showed. Participants with.

article thumbnail

Higher Levels of 'Good' Cholesterol Linked to Increased Glaucoma Risk

Med Page Today

(MedPage Today) -- Higher levels of high-density lipoprotein cholesterol (HDL-C) were associated with an increased risk of glaucoma, while high levels of low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides were associated.

article thumbnail

Should You Take A Statin To Lower Your Cholesterol?

Dr. Paddy Barrett

Only when you have a clear idea of those three factors can you decide whether or not to take a medication to lower your LDL cholesterol. I use statins in the question posed above because that is what most people think and, in fact, what they will start with when looking to lower their LDL cholesterol with a medication. Not zero risk.

article thumbnail

Cholesterol may not be the only lipid involved in trans fat-driven cardiovascular disease

Medical Xpress - Cardiology

Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns. But what if there's more to the picture than just cholesterol?

article thumbnail

More than half of American Indian youth may have abnormal or high cholesterol

Science Daily - Heart Disease

More than 70% of American Indian young adults aged 20-39 and 50% of American Indian teens have cholesterol levels or elevated fat in the blood that put them at risk for cardiovascular disease, a new study suggests.

article thumbnail

Third-Generation PCSK9 Inhibitor Cuts Cholesterol With Single, Small, Monthly Shot

Med Page Today

(MedPage Today) -- ATLANTA -- A novel PCSK9 inhibitor safely reduced LDL cholesterol levels with just a single, quick, once-monthly dose, the phase III LIBerate-HR trial showed. Lerodalcibep reduced LDL cholesterol by 56% more than placebo from.

article thumbnail

New technology 'sees' how cholesterol causes heart attacks

Medical Xpress - Cardiology

government's premier research body has made an important discovery that could help create new drugs to lower "bad" cholesterol, and hopefully prevent heart attacks and stroke.